Universitätsklinikum Essen

Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers (2025) Reitmajer M, Livingstone E, Heinzerling L, Thoms KM, Meiss F, Heppt M, Gesierich A, et al. Journal article High adherence to angiotensin-converting enzyme inhibitor in children and adolescents with Alport syndrome: objective verification using liquid chromatography-mass spectrometry (2025) Boeckhaus J, Tönshoff B, Weber LT, Haffner D, Pape L, Latta K, Fehrenbach H, et al. Journal article Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma—Real-world data from the German research platform CARAT (2025) Goebell P, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, et al. Journal article Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma. (2025) Tomsitz D, Livingstone E, Loquai C, Kaatz M, Leiter U, Schilling B, Terheyden P, et al. Journal article Needs, distress, state-of-health and quality-of-life in survivors of stage III melanoma: Results from the cross-sectional MESSAGE study (2025) Skoda EM, Jansen C, Peltz L, Schweda A, Teufel M, Livingstone E, Zimmer L, et al. Journal article Risk of moderate or severe hypoxic ischemic encephalopathy does not correlate with prenatally known risk factors (2025) Rüdiger M, Kehl S, Wiechers C, Kribs A, Pecks U, Mildenberger E, Glaser K, et al. Journal article Impact of bleeding and thrombosis on outcome of 945 COVID-19 VV-ECMO cases from a German registry (2025) Herrmann J, Schade J, Meybohm P, Paschke N, Hübsch ME, Notz Q, Groene J, et al. Journal article Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. (2025) Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, et al. Journal article Was sind Wundbeläge? Ein Positionspapier der Initiative Chronische Wunden (ICW) e. V. (2025) Dissemond J, Erfurt-Berge C, Gerber V, Motzkus M, Teubner K, Rembe JD Journal article Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral Sclerosis (2025) Steffke C, Baskar K, Bachhuber F, Wiesenfarth M, Dorst J, Schuster J, Schöberl F, et al. Journal article